Drawing for VEO

USPTO serial 87722984

VEO

Reviewed by CopyMark Law Group

Reg. 5524188Status 710
Filing date
Status date
Registration date
Jul 24, 2018
Examiner
FERRAIUOLO, DOMINIC
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with VEO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael A. Marrero

Michael A. Marrero ULMER & BERNE LLP312 WALNUT STREETSUITE 1400CINCINNATI, OH 45202

Goods and services

ClassDescriptionStatusFirst use
035business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical device and pharmaceutical companies to assist them with clinical research, clinical trials, and applications for the approval by governmental regulatory bodies of medical devices, pharmaceuticals, and combination productsSECTION 8 - CANCELLEDDec 15, 2017
045regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for new medical devices and pharmaceuticals or combinations thereof, including but not limited to new medical devices and pharmaceuticals for the eyeSECTION 8 - CANCELLEDDec 15, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 7, 2025C8..CANCELLED SEC. 8 (6-YR)—
Sep 9, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 9, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 9, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 9, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 30, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 24, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 24, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 8, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 8, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 18, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 5, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 26, 2018DOCKASSIGNED TO EXAMINER—
Jan 2, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance